# A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis

> **NCT00550446** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 386 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** Adalimumab
- **DRUG:** CP-690-550
- **DRUG:** CP-690-550
- **DRUG:** CP-690-550
- **DRUG:** CP-690,550
- **DRUG:** CP-690,550
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00550446
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 386 (ACTUAL)
- **Last updated:** 2013-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00550446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00550446, "A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00550446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*